Compound gabapentin mecobalamin dispersible tables and preparation method thereof

A technology of gabapentin methylcobalamin and gabapentin methylcobalamin, which is applied in the field of new pharmaceutical preparations and can solve problems such as the research work of the medicine being carried out by government departments, scientific research institutes and other institutions

Inactive Publication Date: 2008-11-19
北京利乐生制药科技有限公司
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no dosage form of gabapentin mecobalamin on the market in the domestic market, but many pharmaceutical

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0021] Example 1:

[0022] prescription:

[0023] Gabapentin 300g

[0024] Methylcobalamin 0.5g

[0025] Mannitol 25g

[0026] Microcrystalline cellulose 137.5g

[0027] Croscarmellose Sodium Starch 19g

[0028] Cross-linked polyvinylpyrrolidone 8g

[0029] Starch slurry 7g (based on starch)

[0030] Magnesium stearate 3g

[0031] 1000 pieces in total

[0032] Preparation:

[0033] First crush the above-mentioned materials through a 100-mesh sieve, mix gabapentin, mecobalamin, mannitol, microcrystalline cellulose, and mix well, add an appropriate amount of starch slurry to make a soft material, and granulate with a 16-mesh sieve at 60℃ After drying for 3-4 hours, use a 16-mesh sieve to granulate, add disintegrating agent croscarmellose sodium, cross-linked polyvinylpyrrolidone and lubricant magnesium stearate, and after mixing, press to form gabapentin and methylcobalamin dispersion sheet.

Example Embodiment

[0034] Example 2:

[0035] prescription:

[0036] Gabapentin 300g

[0037] Methylcobalamin 0.5g

[0038] Lactose 10.5g

[0039] Pregelatinized starch 42g

[0040] Microcrystalline cellulose 48g

[0041] Low-substituted hydroxypropyl cellulose 18g

[0042] Micro powder silica gel 1.5g

[0043] 1000 pieces in total

[0044] Preparation:

[0045] First crush the above-mentioned materials through a 100-mesh sieve. After fully mixing gabapentin, lactose, pregelatinized starch, microcrystalline cellulose, and low-substituted hydroxypropyl cellulose, adjust the pressure and press to make gabapentin. Amine dispersible tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to gabapentin mecobalamin dispersion tablets for treating peripheral nervous diseases such as psychalgia syndrome, etc. and a preparation method thereof, and aims to make up the disadvantages in the prior art and provide a novel preparation, i.e. the gabapentin mecobalamin dispersion tablets to patients and medical workers; wherein, the gabapentin mecobalamin dispersion tablets have swift disintegration, fast absorption and easy administration, can increase the bioavailability and the blood concentration of drugs, and increase the abirritation. Gabapentin mecobalamin is used as a raw material, auxiliary materials with specific types and proportions are added in, and the mixture is pressed into tablets according to the conventional technique of the preparation course.

Description

technical field [0001] The invention relates to a novel pharmaceutical preparation, in particular to gabapentin mecobalamin dispersible tablets for treating neuropathic pain syndrome and other peripheral neurological diseases and a preparation method thereof. Background technique [0002] Neuropathic pain is a debilitating condition characterized by chronic, recurrent severe nerve pain and is often a complication of common diseases or conditions such as diabetes, herpes, cancer, AIDS multiple sclerosis, stroke, trauma or surgery . [0003] Neuropathic pain is a debilitating disease. The disease is estimated to afflict 2.8% to 4.7% of the world's population. Neuropathic pain can have a major impact on the lives of sufferers, taking away many people's ability to work, walk and even dress, as contact with the skin of neuropathic pain sufferers causes unbearable burning pain . Neuropathic pain is often underdiagnosed and undertreated. Neuropathic pain is caused by damage or...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K31/714A61K47/38A61K47/36A61P25/00A61K31/195
Inventor 王蒙
Owner 北京利乐生制药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap